Cat. No. | Product name | CAS No. |
DCC4704 |
Sgi-10067
PKM2 activator, potently inhibiting proliferation of cancer cells in media lacking serine |
|
DCC4705 |
Sgi-9380
PKM2 activator, potently inhibiting proliferation of cancer cells in media lacking serine |
|
DCC4706 |
Sgk1 Inhibitor 17a
Novel highly selective SGK1 inhibitor with a highly optimized profile suitable for oral dosing as a potentially disease-modifying agent for osteoarthritis |
|
DCC4707 |
Sglt1/2-in-8
Novel Potent SGLT1/2 Dual Inhibitor |
|
DCC4708 |
Sgx393
Novel inhibitor of the CML mutant Bcr-AblT315I, preempting in vitro resistance when combined with nilotinib or dasatinib. |
1030610-86-6 |
DCC4709 |
Sh-053-r-ch3-2’f
Selective agonist of GABA A receptors α5 subunit |
872874-14-1 |
DCC4710 |
Sh-053-s-ch3-2'f
Potent and selective agonist of GABAA receptors α5 subunit |
872874-00-5 |
DCC4711 |
Sh-11037
Novel potent sEH inhibitor, effectively blocking key angiogenic properties of human retinal endothelial cells (HRECs), inhibiting choroidal sprouting and significantly suppressing CNV lesion volume |
|
DCC4712 |
Sh-11052
Novel inhibitor of endothelial cell growth |
|
DCC4713 |
Sh-2251
Novel selective inhibitor of the generation of IL-5-producing Th2 cells and induction of active histone modifications at the IL5 gene locus during Th2 cell differentiation |
|
DCC4714 |
Sha 14-1
Stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypassing drug resistances and synergizing cancer therapies in human leukemia cell |
1033753-87-5 |
DCC4715 |
She-196
First in Class Hypoglycemic Agent with Extra-Strong Action, increasing insulin sensitivity, improving glucose tolerance, reducing fasted insulin level and insulin sensitivity, decreasing total body and interscapular fat mass and also increasing the activi |
|
DCC4716 |
Sherpa Bmi-135
Novel Selective Human ER Partial Agonist (ShERPA) |
|
DCC4717 |
Sheta2
Selective inhibitor of cancer cell growth, exerting chemoprevention activity without evidence of toxicity |
361483-66-1 |
DCC4718 |
Sh-i-14
Novel Inhibitor of Phospho-STAT3 Through Induction of Protein Tyrosine Phosphatase PTPN6 |
|
DCC4719 |
Shield-2
Novel potent stabilizing ligand for FKBP-derived destabilizing domains |
1013621-70-9 |
DCC4720 |
Ship-2a
Cystathione gamma lyase (CSE) inhibitor, inhibiting H2S production and L-cysteine-induced relaxation of rat aortic rings ex vivo |
1250186-20-9 |
DCC4721 |
Showdomycin
Antineoplastic antibiotic |
16755-07-0 |
DCC4722 |
Shp2 Inhibitor C21
Inhibitor of shp2 protein tyrosine phosphatase (PTP) |
293327-21-6 |
DCC4723 |
Shr0687
Highly Potent and Peripheral Nervous System-Restricted KOR Agonist |
|
DCC4724 |
Sibopirdine
Novel cognitive enhancer; Nootropic agent |
122955-18-4 |
DCC4725 |
Sid-24784551
Novel direct HIV-1 Nef antagonist with antiretroviral activity |
332420-75-4 |